Cardio-Oncology: A Win-Win Situation: How Solving the Mystery of an Ibrutinib Off-Target Effect Reveals New Insights Into Atrial Fibrillation Mechanisms

Circulation. 2020 Dec 22;142(25):2456-2458. doi: 10.1161/CIRCULATIONAHA.120.052047. Epub 2020 Dec 21.

Farrukh T Awan^{1

2}, Dan Tong^{3

4}, Vlad G Zaha^{3

2

5

4}

¹ Hematology and Oncology Division (F.T.A.), University of Texas Southwestern Medical Center, Dallas.
² Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center (F.T.A., V.G.Z.), University of Texas Southwestern Medical Center, Dallas.
³ Cardiology Division (D.T., V.G.Z.), University of Texas Southwestern Medical Center, Dallas.
⁴ Parkland Health and Hospital System, Dallas, TX (D.T., V.G.Z.).
⁵ Advanced Imaging Research Center (V.G.Z.), University of Texas Southwestern Medical Center, Dallas.

No abstract available

Keywords: CSK tyrosine-protein kinase; Editorials; atrial fibrillation; src-family kinases.

Publication types